Newsroom | 13163 results

FRISCO, Texas--(BUSINESS WIRE)--Valify, the healthcare industry's leading technology-enabled purchased services platform, hosted its third annual Summit, bringing together healthcare executives, supply chain leaders, strategic sourcing professionals and industry experts from across the country to explore the trends, technologies and strategies shaping the future of healthcare operations. The event featured thought leadership, peer collaboration and practical insights designed to help health sys...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) participated in the 2026 Becker’s CEO + CFO Roundtable held November 2–5 at the Hyatt Regency Chicago, where two executive panel discussions focused on critical challenges facing healthcare organizations: operating room economics and the future of supply chain leadership. The four-day conference brought together more than 1,500 executive-level attendees and more than 450 hospital and health system speakers, creating...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced business updates and financial results for the third quarter ended September 30, 2026. “Pulse Biosciences delivered several major milestones since the second quarter, led by completing enrollment in our U.S. pivotal IDE study in just six months, three months ahead of plan,” said...

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the third quarter ended September 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Over the several weeks since I started, a number of themes have become clear to me. We have strong brands, favorable end markets, and a teammate popula...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--ECA Medical (“ECA” or the “Company”), a leading designer and manufacturer of single-use instruments and surgery-ready solutions for the medical device industry, today announced it has entered into a definitive agreement under which Curewell Capital, a Los Angeles-based private equity firm focused exclusively on healthcare, will acquire a majority stake in the Company from LongueVue Capital. The partnership with Curewell provides significant capital to supp...

HOUSTON & PANAMA CITY--(BUSINESS WIRE)--EndoQuest Robotics, Inc., developer of flexible robotic technology for endoluminal procedures, today announced the successful completion of two robotic transoral gastric reconstruction procedures using the company’s Endoluminal Surgical (ELS) System. Building on the established clinical framework of transoral outlet reduction (TORe), this fully robotic approach uses two-handed instrumentation to precisely perform full-thickness suturing, bringing surgical...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 continuing operations financial summary1 Revenue from continuing operations of $567.8 million, up 0.2% compared to the prior year period, and up 3.0% on a pro forma adjusted constant currency basis1,2 GAAP diluted EPS from continuing operations of $1.30, compared to $(1.32) in the prior year period Adjusted diluted EP...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November and December: Jefferies Healthcare Conference at the Waldorf Hilton, London on November 17, 2026, at 9:00 a.m. Greenwich Time/4:00 a.m. Eastern time. Piper Sandler’s Healthcare Conference at the Lotte New York Palace Hotel, New York...

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Third Quarter 2026...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2026. Norman Schwartz, Bio-Rad’s Chief Executive Officer, stated: “Our third-quarter results reflect the steady progress we have been driving. We returned to currency-neutral revenue growth, led by Clinical Diagnostics and strong demand for our Droplet Digital™...